The Clinical and Theranostic Values of Activated Leukocyte Cell Adhesion Molecule (ALCAM)/CD166 in Human Solid Cancers
Activated leukocyte cell adhesion molecule (ALCAM), also known as CD166, is a cell adhesion protein that is found in multiple cell types. ALCAM has multiple and diverse roles in various physiological and pathological conditions, including inflammation and cancer. There has been compelling evidence o...
Main Authors: | Yiming Yang, Andrew J. Sanders, Q. Ping Dou, David G. Jiang, Amber Xinyu Li, Wen G. Jiang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/20/5187 |
Similar Items
-
Activated Leukocyte Cell Adhesion Molecule (ALCAM), a Potential ‘Seed’ and ‘Soil’ Receptor in the Peritoneal Metastasis of Gastrointestinal Cancers
by: Yi Ming Yang, et al.
Published: (2023-01-01) -
Increase of ALCAM and VCAM-1 in the plasma predicts the Alzheimer’s disease
by: Jian Chen, et al.
Published: (2023-01-01) -
The dual role of CD6 as a therapeutic target in cancer and autoimmune disease
by: Mikel Gurrea-Rubio, et al.
Published: (2022-10-01) -
CD6 and Its Interacting Partners: Newcomers to the Block of Cancer Immunotherapies
by: Lucía Aragón-Serrano, et al.
Published: (2023-12-01) -
Optimization and Characterization of Novel ALCAM-Targeting Antibody Fragments for Transepithelial Delivery
by: Aline Bauer, et al.
Published: (2023-06-01)